Advertisement
Advertisement
U.S. markets open in 1 hour 6 minutes
S&P Futures
4,408.25 +9.00 (+0.20%) Dow Futures
34,399.00 +55.00 (+0.16%) Nasdaq Futures
14,993.50 +35.00 (+0.23%) Russell 2000 Futures
1,859.90 +3.30 (+0.18%) Crude Oil
78.32 -1.32 (-1.66%) Gold
1,932.10 +6.10 (+0.32%)
Accenture plc (ACN)
NYSE - NYSE Delayed Price. Currency in USD
Follow
At close: 04:00PM EDT
Pre-Market:
Advertisement
| Previous Close | 306.51 |
| Open | 309.60 |
| Bid | 309.31 x 900 |
| Ask | 320.72 x 1000 |
| Day's Range | 307.87 - 310.93 |
| 52 Week Range | 242.80 - 327.93 |
| Volume | |
| Avg. Volume | 2,358,000 |
| Market Cap | 195.009B |
| Beta (5Y Monthly) | 1.22 |
| PE Ratio (TTM) | 27.53 |
| EPS (TTM) | 11.22 |
| Earnings Date | Sep 28, 2023 |
| Forward Dividend & Yield | 4.48 (1.46%) |
| Ex-Dividend Date | Jul 12, 2023 |
| 1y Target Est | 338.09 |
ZacksAccenture (ACN) Gains As Market Dips: What You Should Know
Accenture (ACN) closed at $308.90 in the latest trading session, marking a +0.78% move from the prior day.
ZacksHigh Demand and Acquisitions Bode Well for Accenture (ACN)
Accenture (ACN) reaps the benefits of its solid acquisition strategy amid integration risks.
- Zacks
The Zacks Analyst Blog Highlights Accenture, Elevance Health, Analog Devices, Monster Beverage and West Pharmaceutical Services
Accenture, Elevance Health, Analog Devices, Monster Beverage and West Pharmaceutical Services are part of the Zacks top Analyst Blog.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
